FCCM
EBS icon

First City Capital Management’s Emergent Biosolutions EBS Stock Holding History

First City Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-188
Closed -$6.83K – 236
2016
Q1 		$6.83K Hold
188
– – ﹤0.01% 508
2015
Q4 		$7.52K Buy
+188
New +$6.55K 0.01% 500

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

First City Capital Management's EBS Position: Q2 2016 in Review

First City Capital Management sold out of Emergent Biosolutions (EBS) in Q2 2016, closing a stake of 188 shares — an estimated $6.83K sold.

First City Capital Management first reported a position in EBS in Q4 2015 and held it in 2 quarters. The position peaked at $7.52K in Q4 2015. 224 funds tracked by Wall St. Rank hold EBS as of Q2 2016.

  • First City Capital Management reported no remaining Emergent Biosolutions position as of Q2 2016 after selling out during the quarter.
  • First City Capital Management sold 188 Emergent Biosolutions shares in Q2 2016, an estimated $6.83K.
  • First City Capital Management first reported a position in Emergent Biosolutions in Q4 2015 and held it in 2 quarters.
  • First City Capital Management's Emergent Biosolutions position peaked at $7.52K in Q4 2015.
  • 224 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2016.

Based on First City Capital Management's 13F filing for Q2 2016, filed 16 Aug 2016.